###begin article-title 0
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EC-SOD</italic>
Polymorphisms in the Mn-SOD and EC-SOD Genes and Their Relationship to Diabetic Neuropathy in Type 1 Diabetes Mellitus
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 630 636 630 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 674 680 674 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EC-SOD</italic>
###xml 705 713 <span type="species:ncbi:9606">patients</span>
Oxidative stress, resulting in a marked increase in the level of oxygen free radicals (OFR), has been implicated in the etiology of diabetic neuropathy (DN). Antioxidant enzymes may protect against the rapid onset and progression of DN, by reducing the excess of OFR and peroxide. Mutations and polymorphisms in the genes encoding such enzymes may therefore result in predisposition to DN. We investigated the role of genes encoding two antioxidant enzymes, mitochondrial (Mn-SOD) and extracellular (EC-SOD) superoxide dismutase, in DN pathogenesis in a Russian population. We studied Ala(-9)Val and Ile58Thr polymorphisms of the Mn-SOD gene and Arg213Gly dimorphism of the EC-SOD gene in type 1 diabetic patients with (n = 82) and without DN (n = 84).
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsh</italic>
###xml 300 303 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 516 522 516 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
###xml 758 766 <span type="species:ncbi:9606">patients</span>
We developed and used a new polymerase chain reaction (PCR) assays for rapid detection of polymorphisms. These assays involved the use of mismatch PCR primers to create restriction sites in the amplified product only in presence of the polymorphic base. The PCR product was than digested with BshTI, Eco32I or Eco52I to detect Ala(-9)Val, Ile58Thr or Arg213Gly polymorphic site respectively. The frequencies of the Ala allele (50.6% vs. 68.5%, p < 0.002) and the Ala/Ala genotype (17.1% vs. 39.3%, p < 0.005) of the Mn-SOD gene were significantly lower in DN patients than in diabetic subjects without DN. In contrast, the Val allele (49.4% vs. 31.5%, p < 0.002) and the Val/Val genotype (15.9% vs. 2.4%, p < 0.01) were significantly more frequent in the DN patients than in the control group.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
Ala(-9)Val substitution in the Mn-SOD gene was associated with DN in a Russian population
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 561 562 561 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 505 509 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Oxidative stress has been implicated in the etiology of long-term diabetic complications, including peripheral neuropathy [1]. Oxygen free radicals (OFR) may damage neurons by causing nerve lipid peroxidation, the breakdown of mitochondrial DNA and inhibition of the respiratory chain, and the cross-linking of the neurofilament protein [2-4]. Treatment with antioxidants (e.g. probucol, alpha-lipoic acid) decreases lipid peroxidation and oxidative stress in neural tissues and improves the condition of rats with streptozotocin-induced diabetic neuropathy [5,6].
###end p 8
###begin p 9
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Antioxidant enzyme activity is low in in peripheral nerves and even lower in diabetic nerves, possibly due non-enzymatic glycation and autooxidation of the glycated protein [7,8]. Antioxidant enzymes may protect against the rapid onset and progression of diabetic neuropathy (DN) by reducing the excess of both OFR and peroxide. Defects and mutations in the genes encoding these enzymes may therefore lead to suspectibility to DN.
###end p 9
###begin p 10
Superoxide dismutase (SOD) is the key antioxidant enzyme involved in the detoxication of superoxide radicals. SOD is a metalloprotein and its manganese form (Mn-SOD) is present in mitochondria. Two other forms containing cooper and zinc (CuZn) have cytoplasmic or extracellular (EC-SOD) location.
###end p 10
###begin p 11
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
An alanine (GCT) to valine (GTT) substitution at position -9 in the signal peptide of human Mn-SOD has been shown to change the structural conformation of the mitochondrial targeting sequence of the enzyme. Thissubstitution may lead to misdirected intracellular trafficking, followed by changes in Mn-SOD activity in the mitochondria [9,10]. Associations have been found between the Ala(-9)Val dimorphism in the SOD2 gene and such human neurodegenerative and ageing disorders as Parkinson's disease [9], tardive dyskinesia [11], sporadic motor neuron disease [12], and nonfamilial idiopathic dilated cardiomyopathy [13].
###end p 11
###begin p 12
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
The Ile58Thr amino acid exchange destabilizes the tetrameric interface of Mn-SOD and reduces its enzymatic activity [14]. This finding suggests that the Ile58Thr polymorphism may be associated with neurodegenerative diseases involving a decrease in Mn-SOD levels [15]. However, no association between the Ile58Thr polymorphism and Parkinson's disease was found in German patients [16].
###end p 12
###begin p 13
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
Extracellular superoxide dismutase (EC-SOD) has an amino acid substitution Arg213Gly in the heparin-binding domain [17]. The glycine variant of the enzyme is responsible for high EC-SOD levels in serum [18,19] that are correlated with a decrese in nitric oxide production in epithelial cells [20] and various other metabolic cardiovascular risk factors [21]. A relationship was found between the Arg213Gly dimorphism and familial amyloidotic (non-diabetic) in a Japanese population, involving greater dissociation of EC-SOD from the vascular wall followed by extensive oxidative stress and cardiac, renal, and autonomic nervous system failure due to massive amyloid deposition [22].
###end p 13
###begin p 14
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EC-SOD</italic>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 266 272 266 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EC-SOD</italic>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
In this study, we investigated whether allelic variants of the Mn-SOD and EC-SOD genes were involvedin the etiology of DN in Russian type 1 diabetic patients. To do this, we developed new methods for the simple and rapid detection of polymorphisms in the Mn-SOD and EC-SOD genes.
###end p 14
###begin title 15
Materials and Methods
###end title 15
###begin title 16
Subjects
###end title 16
###begin p 17
###xml 225 237 <span type="species:ncbi:9606">participants</span>
In this study, 88 healthy Russian donors selected at random (59 males and 29 females, mean age 28.3 +/- 8.4 years, mean +/- SEM) were examined. Healthy subjects had no autoimmune, cardiovascular, or other diseases. All study participants lived in Moscow or the Moscow region. Blood samples were collected in the Department of Endocrinology and Diabetology of the Russian Academy for Advanced Medical Studies. This study was approved by the Academy Review Board and was carried out in accordance with the principles of the second Helsinki Declaration. Informed consent was obtained from all subjects before participation in this study.
###end p 17
###begin p 18
###xml 1868 1869 1862 1863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 218 226 <span type="species:ncbi:9606">patients</span>
###xml 267 275 <span type="species:ncbi:9606">Patients</span>
###xml 847 855 <span type="species:ncbi:9606">patients</span>
###xml 1011 1019 <span type="species:ncbi:9606">patients</span>
###xml 1343 1351 <span type="species:ncbi:9606">patients</span>
###xml 1612 1620 <span type="species:ncbi:9606">patients</span>
###xml 1728 1736 <span type="species:ncbi:9606">patients</span>
We studued a total of 166 genetically unrelated Russian patients affected with type 1 diabetes mellitus (97 males and 69 females, mean age 25.0 +/- 13.4 years, mean duration of diabetes 9.6 +/- 9.2 years). None of the patients studied were treated with antioxidants. Patients with causes of neuropathy other than diabetes (e. g. chronic alcohol abuse, drug-induced neuropathy), truncal neuropathy, and significant neurological diseases (e.g. Parkinson's disease, epilepsy, multiple sclerosis) were excluded from the association study. DN was diagnosed on the basis of symptomatic symmetrical distal neuropathy (reduced/absent ankle reflexes, reduced vibration, thermal, tactile, pin-prick, and/or position sensation) with one or more typical symptoms (burning pains or cramps, paresthesiae, numbness) of at least moderate severity in the feet. DN patients were also identified by measuring the motor conduction velocity of the peroneal nerve, with a velocity of <42 m/s (mean 31.6 +/- 1.0 m/s) used to identify patients with DN. Accompanying retinopathy was diagnosed based on the presense of microaneurysms together with hard exudates and retinal hemorrhages, new vessel formation and/or fibrous retiniis proliferans Clinical nephropathy was diagnosed on basis of persistent proteinuria (urinary protein excretion rate > 0.3 g/24 h). The 166 patients tested were assigned to two groups according to the duration of diabetes. The groups were formed using principal of extreme phenotype and nonoverlapping selection criteria to minimize the masking effects of non-genetic factors. The first group consisted of 82 patients with diabetes of short duration (<3 years) and DN. The other group contsisted of the ramaining 84 diabetic patients, all of whom had diabetes of long duration (>10 years) and no neuropathy. The characteristics of the two groups are shown in Table 1.
###end p 18
###begin p 19
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of the patients
###end p 19
###begin p 20
###xml 27 28 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Values are mean +/- SEM or a percentage of patients
###end p 20
###begin title 21
Genomic DNA isolation and genotyping of Mn-SOD
###end title 21
###begin p 22
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 605 611 604 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
DNA was extracted from whole human blood with phenol and chloroform [23]. Polymorphic regions were amplified by polymerase chain reaction (PCR) in 50 mul reaction mixture consisting of 67 mM Tris-HCl (pH 8.8), 16.7 mM ammonium chloride, 1.0 mM magnesium chloride, 0.1% Tween-20, 10% dimethyl sulfoxide, 0.2 mM of each dNTP, 5 pmol of each primer, 100 ng of genomic DNA, and 2.5 units of Taq polymerase (Biotekh, Russia). To amplify the polymorphic Ala(-9)Val region, we used primers SOD2-16F 5'-CCAGCAGGCAGCTGGCACCG-3' and SOD2-16R 5'-TCCAGGGCGCCGTAGTCGTAGG-3'. For the polymorphic Ile58Thr region of the Mn-SOD gene, PCR primers SOD2-58F 5'-AAGCTCCTCCCATTATCTAATAGC-3' and SOD2-58R 5'-TCAGTGCAGGCTGAAGAGAT-3' were used. PCR was carried out in a PHC-2 thermal cycler (Techne, UK) with 35 cycles of denaturation for 1 min at 94degreesC, annealing for 1 min at 55degreesC (Ile58Thr) or 60degreesC (Ala(-9)Val), and extension for 1 min at 72degreesC.
###end p 22
###begin p 23
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsh</italic>
###xml 146 149 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 250 251 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 280 281 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 598 600 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
To detect Ala(-9)Val dimorphism, the PCR product was digested with BshTI. For the Ile58Thr polymorphism, the amplified fragment was digested with Eco32I (both enzymes from Fermentas, Lithuania). For digestion, 17 mul of PCR product, 2 mul of buffer O+/Tangotrade mark (BshTI) or R+/Tangotrade mark (Eco32I) (all buffers from Fermentas, Lithuania), and 1 mul of restriction endonuclease (1 unit/mul) were mixed and incubated for 12 h at 37degreesC. Digested DNA products were separated by electrophoresis in a 3% agarose gel with ethidium bromide or in an 8% polyacrylamide gel stained with silver [24].
###end p 23
###begin title 24
Genotyping of Arg213Gly EC-SOD
###end title 24
###begin p 25
###xml 526 529 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 559 562 552 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 719 726 712 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD.</italic>
The polymorphic region was amplified in a 50 mul reaction mixture consisting of 10 mM Tris-HCl (pH 8.8), 50 mM KCl, 1.5 mM magnesium chloride, 0.1% Tween-20, 10% dimethyl sulfoxide, 0.2 mM of each dNTP, 5 pmol of each primer SOD3-213F 5'-GGCTGGCCTGCTGCGTGGTGG-3' and SOD3-213R 5'-CCTTGCACTCGCTCTCGCGCG-3', 100 ng of genomic DNA, and 2.5 units of Taq polymerase. The PCR cycling profile was as described above except that annealing was carried out for 1 min at 65degreesC the amplicon was cleaved with restriction endonuclease Eco52I (Fermentas, Lithuania) in Eco52I+ specific buffer according to the manufacturer's recommendations. Digested fragments were analyzed as described by electrophoresis for the genotyping of Mn-SOD.
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
###xml 90 91 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 191 193 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 390 391 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 519 525 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 529 535 527 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EC-SOD</italic>
Genotype frequencies were checked for deviation from Hardy-Weinberg equilibrium by the chi2 and G-statistic tests, using the Rows and Columns program based on the Roff and Bentzen algorithm [25]. Genotype and allele frequencies in the groups studied were compared by Fisher's exact test The p value was corrected by multiplying it by the number of alleles (2) for each locus to obtain the pc value. Odds ratios and 95% confidence interval (95% CI) were calculated to assess the strength of the relationship between the Mn-SOD or EC-SOD polymorphisms and DN.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
The Ala(-9)Val polymorphism of the Mn-SOD gene
###end title 29
###begin p 30
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 381 384 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsh</italic>
###xml 497 500 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsh</italic>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
The first adenosine residue from 3' end of the forward primer, SOD2-16F, is mismatched with genomic DNA. The original sequence, near the polymorphic site of the Mn-SOD gene, is 5'-TCCGGT-3' with the most variable 3' thymidine (Val) to cytidine (Ala) at position -9 [26]. Use of the mismatched primer, SOD2-16F, results in a 91-bp PCR product. This product may or may not contain a BshTI restriction site (5'-ACCGGT-3'), depending on the sequence. If the -9 codon is GTT (Val), than digestion with BshTI produces two DNA fragments, 17 and 74 bp in length. If codon -9 is GCT (Ala), the amplified product not digested with this enzyme (Fig. 1).
###end p 30
###begin p 31
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsh</italic>
###xml 297 301 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hinf</italic>
Restriction analysis of Ala(-9)Val polymorphism in the SOD2 gene. Lanes 2-14: 13 samples after digestion with BshT1; lanes 2, 3, 5, 8, and 10, Ala/Ala genotype; lanes 4, 7, 9, 12, and 14, Ala/Val genotype; lanes 6, 11, and 13, Val/Val genotype. Lanes 1 and 15: molecular weight DNA marker phiX174/HinfI; 100-, 82- and 60-bp DNA fragments are shown.
###end p 31
###begin p 32
###xml 88 89 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 223 224 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
The Ala allele and the Ala/Val genotype were the most common in healthy subjects (Table 2). The observed level of heterozygosity was 53.4%. The observed genotype frequency was consistent with Hardy-Weinberg equilibrium (chi2 = 2.0976 and G-statistic = 2.1149, p = 0.3930 +/- 0.0154).
###end p 32
###begin p 33
Allele and genotype distribution of the Ala(-9)Val SOD2 and Arg213Gly SOD3 polymorphic markers in healthy subjects
###end p 33
###begin p 34
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
The frequencies of the Ala allele and the Ala/Ala genotype were significantly lower in patients with DN than in patients without DN whrereas the frequency of the Val allele and the homozygous Val/Val genotype was significantly higher in patients with DN (Table 3). This suggests that the Ala(-9)Val dimorphism in the Mn-SOD gene is associated with neuropathy in type 1 diabetes mellitus. The Ala allele (odds ratio = 0.48, 95% CI; 0.31-0.74) and the Ala/Ala genotype (odds ratio = 0.34, 95% CI; 0.17-0.66) are associated with lower risk of DN development in than the Val allele (odds ratio = 2.09, 95% CI; 1.35-3.24) and the Val/Val genotype (odds ratio = 5.10, 95% CI; 1.77-14.69).
###end p 34
###begin p 35
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Allele and genotype distribution of the Ala(-9)Val SOD2 polymorphic marker in type 1 diabetic patients with and without neuropathy
###end p 35
###begin p 36
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 161 162 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 175 176 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 337 338 337 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 518 519 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 699 700 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 50 58 <span type="species:ncbi:9606">patients</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 407 415 <span type="species:ncbi:9606">patients</span>
###xml 589 597 <span type="species:ncbi:9606">patients</span>
a Ala allele frequency was significantly lower in patients with diabetic neuropathy than in subjects without this complication (odds ratio = 0.48, p = 0.00067, pc = 0.00134). b Val allele frequency was significantly higher in patients with diabetic neuropathy than in subjects without this complication (odds ratio = 2.10, p = 0.00067, pc = 0.00134). c Ala/Ala genotype frequency was significantly lower in patients with diabetic neuropathy than in subjects without this complication (odds ratio = 0.34, p = 0.00122, pc = 0.00366). d Val/Val genotype frequency was significantly higher in patients with diabetic neuropathy tha in subjects without this complication (odds ratio = 5.10, p = 0.00219, pc = 0.00657).
###end p 36
###begin title 37
The Ile58Thr polymorphism of the Mn-SOD gene
###end title 37
###begin p 38
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 363 366 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
The penultimate adenosine residue at 3' end of the reverse primer SOD2-58R used is not complemetary to the genomic sequence (5'-GATAGC-3'), creating an Eco32I restriction site (5'-GATATC-3') during amplification if codon 58 is ATA (Ile) [26]. In this case, a 140-bp PCR product is produced, which yields two fragments, 20-bp and 120-bp in size, on digestion with Eco32I. If codon 58 is ACA (Thr allele) the amplified product not cleaved by this enzyme.
###end p 38
###begin p 39
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
###xml 257 264 <span type="species:ncbi:9606">patient</span>
###xml 396 404 <span type="species:ncbi:9606">patients</span>
Eighty-seven of the 88 healthy subjects displaied the Ile/Ilegenotype, the remaining subject was heterozygous, Ile/Thr. All of the diabetic patients without complications were homozygous (Ile/Ile), as were all but one of the patients with DN, the remaining patient being heterozygous. So, no association between the Ile58Thr polymorphism of the Mn-SOD gene and DN was observed in type 1 diabetic patients.
###end p 39
###begin title 40
The Arg213Gly polymorphism of the EC-SOD gene
###end title 40
###begin p 41
###xml 163 169 163 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EC-SOD</italic>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 435 438 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
The last guanosine residue at the 3' end of the reverse primer, SOD3-231R, displays a mismatch with the original sequence, 5'-CGGCGG-3', close to codon 213 of the EC-SOD gene. This resulted (depending on the sequence) in creation of an Eco52I restriction site (5'-CGGCCG-3') in the PCR product [19]. If codon 213 was CGG (Arg), a 104-bp PCR product was obtained that yielded two DNA fragments of 23 and 81 bp in size on digestion with Eco52I. In contrast, if codon 213 was GGG (the Gly allele), the 104-bp product was not digested with the enzyme (Fig. 2).
###end p 41
###begin p 42
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msp</italic>
Restriction analysis of Arg213Gly polymorphism at the SOD3 gene. Lanes 1-3, 5-12: 11 samples after digestion with Eco521; lanes 3, 7, and 11, Arg/Arg genotype; lanes 1, 2, 8, 10, and 12, Arg/Gly genotype; lanes 5, 6, and 9, Gly/Gly genotype. Lane 4: molecular weight DNA marker pBR322/MspI; 90- and 76-bp DNA fragments are shown.
###end p 42
###begin p 43
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 302 303 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 486 487 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 526 532 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EC-SOD</italic>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
###xml 459 467 <span type="species:ncbi:9606">patients</span>
The Arg allele was 1.9 times more frequent than the Gly allele in healthy subjects. Arg/Arg homozygotes were 5.7 times more frequent than Gly/Gly homozygotes (Table 2). The observed level of heterozygosity was 54.6%. The observed genotype distribution was consisted with Hardy-Weinberg equilibrium (chi2 = 1.9495 and G-statistic = 1.9614, p = 0.3980 +/- 0.0155). No significant difference in allele and genotype distribution was found between DN patients and patients without DN (Table 4). Thus, Arg213Gly substitution in the EC-SOD gene is not associated with nerve lesions in type 1 diabetes mellitus.
###end p 43
###begin p 44
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Allele and genotype distribution of the Arg213Gly SOD3 polymorphic marker in type 1 diabetic patients with and without neuropathy
###end p 44
###begin title 45
Discussion and Conclusions
###end title 45
###begin p 46
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsa</italic>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 615 618 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsh</italic>
###xml 730 733 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsa</italic>
###xml 1423 1425 1423 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1513 1515 1513 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
A number of techniques have been described for detection of the Ala (-9)Val Mn-SOD gene dimorphism. One such method is PCR amplification of the polymorphic region, followed by BsaWI treatment (i. e., PCR/restriction fragment length polymorphism, PCR/RFLP) [16]. Another method is single-strand conformational polymorphism (SSCP) analysis of the product amplified by PCR [9]. A third method is two-step PCR using allele-specific primers for a second round of PCR [10]. Finally, the PCR product can be hybridized with allele-specific oligonucleotide (ASO) probes [13]. We have decided to use restriction endonuclease BshT1 for detection of the Ala(-9)Val polymorphism because this enzyme is commercially available in Russia whereas BsaWI is not. Our detection method has advantages over other techniques because is no need to carry out using the second round of PCR or laborious procedure of SSCP analysis after PCR amplification. Our molecular assay involves use of the mismatch-PCR/RFLP approach, which can be applied to the detection of any polymorphic single base substitution that fails to create or eliminates restriction sites. This rapid assay requires no special equipment or expertise. The use of a mismatch PCR primer makes it possible to create a restriction site in the amplified product only in the presence of the polymorphic base. This approach has been used to genotype the M235T variant of angiotensinogen [27] and the C1166T nucleotide variation in the angiotensinogen II (type 1) receptor gene [28].
###end p 46
###begin p 47
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
The Ala allele of the Mn-SOD gene was more widespread than the Gly allele in healthy Russian subjects. This feature is common to all other Caucasian population samples tested (Germans, Swedes, Lithuanians, Finns, and Saamis) [16,29]. In contrast, the frequency of the Ala variant is significantly lower in Asian populations (Chinese and Japanese) than in most European populations [9,11,13,29].
###end p 47
###begin p 48
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
The Ala/Val variation in the Mn-SOD leader signal affects the processing efficiency of the enzyme. The conformations of the Ala-type and Val-type leader signals have been predicted: the Ala form has an alpha-helical structure, a common conformation for mitochondrial leader signals, whereas the Val form may change its conformation from alpha-helix to beta-sheet starting from the position 16 due to amino acid substitution [9]. The Val form is less efficiently transported into mitochondria than the Ala form of the enzyme [9]. Poor signal sequence recognition by a receptor in the inner mitochondrial membrane may result in mistargeting. In addition, inefficient cleavage of a particular signal may reduce the level of enzymatic activity of an imported protein, such as Mn-SOD, within the mitochondrial compartment [30]. Studies of processing have suggested basal level of the Mn-SOD activity may be highest for Ala/Ala, followed by Ala/Val, and then Val/Val [13].
###end p 48
###begin p 49
###xml 364 370 364 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 686 687 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
###xml 390 398 <span type="species:ncbi:9606">patients</span>
The Val variant of the Mn-SOD may be present in a lower concentration in mitochondria. If this is the case, then homozygous Val/Val should have lower resistance to oxidative stress than patients with other Mn-SOD variants. Such lower resistance is a common feuature of diabetes mellitus and various ageing and neurological disorders. This study showed that the ValMn-SOD allele predisposed patients to the development of DN in type 1 diabetes mellitus. Inefficient targeting of Mn-SOD may leave mitochondria inabequately defended against superoxide radicals. This may lead to protein oxidation, mitochondrial DNA mutations and damage, common in the pathogenesis of diabetic neuropathy [2,3] and neurodegenerative disorders such as Alzheimer and Parkinson's disease [31].
###end p 49
###begin p 50
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 82 86 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The Ala/Val dimorphic site is located within exon 2 of the Mn-SOD gene. Knock-out mice lacking exons 1 and 2 of Mn-SOD have been found to display progressive motor disturbances due to neuronal degeneration [32]. This observation provides future evidence for the involvement of the SOD2 gene in neuropathology.
###end p 50
###begin p 51
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mn-SOD</italic>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 753 759 <span type="species:ncbi:9606">people</span>
Another functional polymorphism of the Mn-SOD gene, Ile58Thr in exon 3, affects the stability of the Mn-SOD tetramer and reduces the activity of the enzyme [14]. However, the Thr allele has been shown to be extremely rare. Our data consistent with those of Grasbon-Frodl et al. [16] who detected the Ile/Ile variant in only 63 randomly selected German subjects. The Ile58Thr variation of Mn-SOD probably not involved in DN pathogenesis. However this mutation is more likely to be involve in hereditary aging-related neurodegenerative disease, as shown by the finding that leukocytes lose the ability to induce Mn-SOD expression in response to increases in reactive oxygen species levels in tissue, in subjects over the age of 55 years [14]. Thus, older people with genetic defects in the four-helix bundle tetrameric interface of Mn-SOD may be especially prone to degenerative diseases.
###end p 51
###begin p 52
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 743 751 <span type="species:ncbi:9606">patients</span>
###xml 970 978 <span type="species:ncbi:9606">patients</span>
An Arg213Gly substitution in the extracellular isoform (EC-SOD) does not affect enzymatic activity but does affect the amount of the enzyme on the external endothelial cell surface [33]. The Arg variant of EC-SOD is the most common in varios populations [17,18] including the Russian population (Table 2). Arginine-to-glycine substitution occurs in the center of the carboxyl-terminal cluster of positively charged amino acid residues defining the heparin-binding domain [17]. This amino acid substitution results in a higher level of dissociation of the enzyme from the cell surface into serum. Thus, the lower levels of EC-SOD on vascular walls must be positively correlated with a higher risk of progression of oxidative stress in affected patients with the Gly/Gly genotype. However, this finding was not supported by our data which showed a lack of association of the polymorphic marker with diabetic neuropathy. Such a relationship has been found only in Japanese patients with non-diabetic form of neuropathy resulting from massive amyloid deposition in nervous tissues [22].
###end p 52
###begin p 53
Finally, we have no comparative data concerning the role of genetic factors directly related to oxidative stress in DN formation and progression. It would be of value to compare our findings with those of similar association studies in other populations.
###end p 53
###begin title 54
Pre-publication history
###end title 54
###begin p 55
The pre-publication history for this paper can be accessed here:
###end p 55
###begin p 56

###end p 56
###begin title 57
Acknowledgements
###end title 57
###begin p 58
We thank Dr. I.A. Strokov for the collection of blood samples.
###end p 58
###begin article-title 59
Oxidative glycation and free radical production: a causal mechanism of diabetic complications.
###end article-title 59
###begin article-title 60
The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy.
###end article-title 60
###begin article-title 61
Formation and structure of cross-linking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides, and protein.
###end article-title 61
###begin article-title 62
Metabolic and vascular factors in the pathogenesis of diabetic neuropathy.
###end article-title 62
###begin article-title 63
Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.
###end article-title 63
###begin article-title 64
###xml 67 71 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration.
###end article-title 64
###begin article-title 65
Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved.
###end article-title 65
###begin article-title 66
Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase.
###end article-title 66
###begin article-title 67
###xml 69 74 <span type="species:ncbi:9606">human</span>
Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene.
###end article-title 67
###begin article-title 68
On signal sequence polymorphisms and diseases of distribution.
###end article-title 68
###begin article-title 69
Manganese superoxide dismutase gene polymorphism and schizophrenia. Relation to tardive dyskinesia.
###end article-title 69
###begin article-title 70
Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease.
###end article-title 70
###begin article-title 71
Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese.
###end article-title 71
###begin article-title 72
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface.
###end article-title 72
###begin article-title 73
Genetic polymorphisms in Parkinson's disease.
###end article-title 73
###begin article-title 74
###xml 148 156 <span type="species:ncbi:9606">patients</span>
Analysis of mitochondrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients.
###end article-title 74
###begin article-title 75
###xml 20 25 <span type="species:ncbi:9606">human</span>
10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain.
###end article-title 75
###begin article-title 76
Molecular analysis of extracellular-superoxide dismutase gene associated with high level in serum.
###end article-title 76
###begin article-title 77
Polymorphism of extracellular superoxide dismutase (EC-SOD) gene: relation to the mutation responsible for high EC-SOD level in serum.
###end article-title 77
###begin article-title 78
Association of extracellular-superoxide dismutase phenotype with the endothelial constitutive nitric oxide synthase polymorphism.
###end article-title 78
###begin article-title 79
Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population.
###end article-title 79
###begin article-title 80
Familial amyloidotic polyneuropathy type I with extracellular superoxide dismutase mutation: a case report.
###end article-title 80
###begin article-title 81
The isolation of high molecular weight eukaryotic DNA.
###end article-title 81
###begin article-title 82
Analysis of the VNTR locus D1S80 by PCR followed by high-resolution PAGE.
###end article-title 82
###begin article-title 83
###xml 64 65 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
The statistical analysis of mitochondrial DNA polymorphisms: chi2 and the problem of small samples.
###end article-title 83
###begin article-title 84
Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping.
###end article-title 84
###begin article-title 85
Linkage of the angiotensinogen gene to essential hypertension.
###end article-title 85
###begin article-title 86
###xml 34 38 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1166</sup>
A simple molecular assay for the C1166 variant of the angiotensin II type 1 receptor gene.
###end article-title 86
###begin article-title 87
Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD.
###end article-title 87
###begin article-title 88
###xml 32 39 <span type="species:ncbi:9606">patient</span>
MnSOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control.
###end article-title 88
###begin article-title 89
Oxidative stress in Parkinson's disease and other neurodegenerative disorders.
###end article-title 89
###begin article-title 90
###xml 34 38 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
A novel neurological phenotype in mice lacking mitochondrial superoxide dismutase.
###end article-title 90
###begin article-title 91
Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface.
###end article-title 91

